Projects ongoing (click on the picture to have short a description):

Arcadia1 ARCADIA: nAtural compounds targeting nuclear Receptors: from Computer Aided Design to Innovative commercial formulAtions (CTI project 2017-2018) dendrons Dendritic molecules for DNA/siRNA delivery in pulmunary diseases, SNF project (2016-2018)
 g5 Novel micellar drug carrier systems for gene therapies, SNF Project NOMIGE with UNIGE (2015-2017)  GHSR GHSR-1 targeting compounds
Cameo2  Toll-like receptors 7 modulators  Diapositiva35 Molecular mechanisms related to the effect of new drugs against Ataxia of type 3
coarsegrain Multiscale Coarse Graining approach with Wavelets

Short CV:

Dr. Andrea Danani is presently working at IDSIA, the Dalle Molle Institute for Artificial Intelligence affiliated to USI and SUPSI, where he leads a computational biophysics unit.
He received the Dipl.-Ing degree in Physics from ETH in Zurich in 1987. After Ph.D. degrees at SISSA/ISAS in Trieste in 1992, he worked with a post-doctoral postion for many years at several Physics Departments (Politecnico di Torino, Università Statale of Milano and Università di Genova) and as scientific collaborator by the Swiss National Supercomputing Center (CSCS) in Manno. His scientific activity was first centered on the modellization of many-electron systems and their phase transitions and later on the description of surface diffusion of adatoms in metals using analytical models and several numerical simulation methods like Cluster Variation Method, MonteCarlo and Molecular dynamics. At CSCS, he also organized camps for swiss students (C3-Campus) in applied informatics. Since 2000, Dr Danani works at SUPSI as scientific collaborator and teacher, where he received the Professor title in 2006. He has been project leader of more than ten projects related to the numerical simulation and the modellization of several systems mainly at the molecular level: polymer nanocomposites, biological systems in interaction with drugs and DNA/RNA with related structure-based virtual screening, macromolecules for drug delivery, protein/protein interaction for neurodegenerative problems.